Fatima Akdim

2.4k total citations
24 papers, 871 citations indexed

About

Fatima Akdim is a scholar working on Surgery, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fatima Akdim has authored 24 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Physiology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fatima Akdim's work include Lipoproteins and Cardiovascular Health (10 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Fatima Akdim is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Fatima Akdim collaborates with scholars based in Netherlands, United States and Canada. Fatima Akdim's co-authors include John J.P. Kastelein, Erik S.G. Stroes, Diane L. Tribble, Sander I. van Leuven, Brenda F. Baker, JoAnn Flaim, John Q. Su, Rosie Z. Yu, Raphaël Duivenvoorden and Michiel L. Bots and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The American Journal of Medicine.

In The Last Decade

Fatima Akdim

20 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fatima Akdim Netherlands	12	424	311	239	190	164	24	871
Luigi Cavuto Italy	14	257 0.6×	413 1.3×	144 0.6×	268 1.4×	100 0.6×	14	902
Mathias Burgmaier Germany	20	420 1.0×	354 1.1×	283 1.2×	265 1.4×	54 0.3×	55	1.0k
Julian C. van Capelleveen Netherlands	13	608 1.4×	330 1.1×	293 1.2×	175 0.9×	204 1.2×	16	925
Sophie J. Bernelot Moens Netherlands	16	301 0.7×	184 0.6×	182 0.8×	194 1.0×	98 0.6×	23	823
Denise D’Andrea United States	14	385 0.9×	166 0.5×	309 1.3×	138 0.7×	147 0.9×	29	862
Steve Martin Canada	11	192 0.5×	216 0.7×	226 0.9×	99 0.5×	100 0.6×	17	634
Simone L. Verweij Netherlands	11	370 0.9×	208 0.7×	126 0.5×	94 0.5×	111 0.7×	14	713
Seung Ho Hong South Korea	17	242 0.6×	204 0.7×	204 0.9×	236 1.2×	102 0.6×	40	860
Tiziana Sampietro Italy	18	594 1.4×	299 1.0×	356 1.5×	195 1.0×	156 1.0×	75	1.1k
Olivier Tricot France	14	333 0.8×	651 2.1×	88 0.4×	202 1.1×	83 0.5×	31	1.0k

Countries citing papers authored by Fatima Akdim

Since Specialization

Citations

This map shows the geographic impact of Fatima Akdim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Akdim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Akdim more than expected).

Fields of papers citing papers by Fatima Akdim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatima Akdim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Akdim. The network helps show where Fatima Akdim may publish in the future.

Co-authorship network of co-authors of Fatima Akdim

This figure shows the co-authorship network connecting the top 25 collaborators of Fatima Akdim. A scholar is included among the top collaborators of Fatima Akdim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatima Akdim. Fatima Akdim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bakker, Annelies L.M., Fatima Akdim, Ruth G.M. Keijsers, et al.. (2025). The role of FDG-PET/CT in assessing cardiac sarcoidosis with no high-risk cardiac features and normal CMR. European Heart Journal - Cardiovascular Imaging. 26(5). 830–837.

Grutters, Jan C., Marcel Veltkamp, Ruth G.M. Keijsers, et al.. (2024). Holter Monitoring and Cardiac Biomarkers in Screening for Cardiac Sarcoidosis. Lung. 203(1). 10–10. 3 indexed citations

Keijsers, Ruth G.M., E.M.W. van de Garde, Marcel Veltkamp, et al.. (2023). Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis. Journal of Nuclear Cardiology. 30(4). 1543–1553. 11 indexed citations

Bakker, Annelies L.M., Martin J. Swaans, Marcel Veltkamp, et al.. (2021). Effectiveness and safety of infliximab in cardiac Sarcoidosis. International Journal of Cardiology. 330. 179–185. 25 indexed citations

Keijsers, Ruth G.M., Annelies L.M. Bakker, Fatima Akdim, et al.. (2021). The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis. EJNMMI Research. 11(1). 129–129. 5 indexed citations

Bakker, Annelies L.M., et al.. (2021). Value of echocardiography using knowledge-based reconstruction in determining right ventricular volumes in pulmonary sarcoidosis: comparison with cardiac magnetic resonance imaging. International journal of cardiac imaging. 38(2). 309–316.

Bakker, Annelies L.M., Jippe C. Balt, Vincent F. van Dijk, et al.. (2021). Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis. Heart Rhythm. 19(3). 352–360. 8 indexed citations

Akdim, Fatima, Diane L. Tribble, JoAnn Flaim, et al.. (2011). Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia. European Heart Journal. 32(21). 2650–2659. 102 indexed citations

Akdim, Fatima, Erik S.G. Stroes, Eric J.G. Sijbrands, et al.. (2010). Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy. Journal of the American College of Cardiology. 55(15). 1611–1618. 128 indexed citations

10.

Akdim, Fatima, Maartje E. Visser, Diane L. Tribble, et al.. (2010). Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia. The American Journal of Cardiology. 105(10). 1413–1419. 141 indexed citations

11.

Bisoendial, Radjesh J., Rakesh S. Birjmohun, Fatima Akdim, et al.. (2009). C-Reactive Protein Elicits White Blood Cell Activation in Humans. The American Journal of Medicine. 122(6). 582.e1–582.e9. 36 indexed citations

12.

Visser, Maartje E., Fatima Akdim, Diane L. Tribble, et al.. (2009). Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia. Journal of Lipid Research. 51(5). 1057–1062. 88 indexed citations

13.

Visser, Marjolein, Fatima Akdim, Dick C.G. Basart, et al.. (2009). Abstract: 104 EFFECT OF MIPOMERSEN TREATMENT ON HEPATIC TRIGLYCERIDE CONTENT IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA. Atherosclerosis Supplements. 10(2). e229–e229. 1 indexed citations

14.

Kastelein, John J.P., Fatima Akdim, E.S.G. Stroes, et al.. (2008). Simvastatin with or without ezetimibe in familial hypercholesterolemia (vol 358, pg 1431, 2008). New England Journal of Medicine. 358(18). 10 indexed citations

15.

Groot, Eric de, Sander I. van Leuven, Raphaël Duivenvoorden, et al.. (2008). Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis. Nature Clinical Practice Cardiovascular Medicine. 5(5). 280–288. 203 indexed citations

16.

Harchaoui, Karim El, Fatima Akdim, Erik S.G. Stroes, Mieke D. Trip, & John J.P. Kastelein. (2008). Current and Future Pharmacologic Options for the Management of Patients Unable to Achieve Low-Density Lipoprotein-Cholesterol Goals with Statins. American Journal of Cardiovascular Drugs. 8(4). 233–242. 19 indexed citations

17.

Akdim, Fatima, et al.. (2007). Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?. Current Pharmaceutical Design. 13(10). 1003–1012. 26 indexed citations

18.

Akdim, Fatima, et al.. (2007). Antisense Apolipoprotein B-100 As Novel Treatment For Hypercholesterolemia: Focus On Isis 301012. Pure Amsterdam UMC. 2(4). 387–393. 6 indexed citations

19.

Akdim, Fatima, Mieke D. Trip, Eric J.G. Sijbrands, et al.. (2007). PO23-746 ISIS 301012, AN ANTISENSE INHIBITOR OF APO B, PRODUCES SIGNIFICANT ADDITIONAL REDUCTION OF LDL-C & APOB IN HYPERCHOLESTEROLEMIC SUBJECTS ON STATINS NOT MEETING TARGET. Atherosclerosis Supplements. 8(1). 198–199. 5 indexed citations

20.

Akdim, Fatima, Erik S.G. Stroes, & John J.P. Kastelein. (2007). Antisense apolipoprotein B therapy: where do we stand?. Current Opinion in Lipidology. 18(4). 397–400. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact